A new tool to predict who may drop out of addiction treatment: The PDAT-13 scale

What is it about?

People with addictions often leave treatment programmes before completing them. This is a common and serious challenge in clinical practice because dropping out early often leads to poor outcomes and an increased risk of relapse, which makes recovery more difficult. Although the core areas that may increase dropout risk have been identified, we found no tools that assess them simultaneously in a practical, clinical way. The ability to predict who might leave treatment early would enable professionals to provide timely support in specific areas. We have therefore developed a brief, clinically applicable questionnaire called the Predictors of Dropout from Addiction Treatment (PDAT-13) scale. The questionnaire asks about four core psychological and motivational areas that influence treatment retention: 1. Motivation: the patient's drive to recover and engage with the treatment. 2. Craving: strong urges to return to substance use. 3. Problem awareness: how well the patient understands their addiction and its impact. 4. Dysphoria: emotional discomfort, such as anxiety, restlessness, or a low mood. The tool was tested on 243 patients receiving addiction treatment at centres across Spain. It reliably predicted whether someone was at risk of leaving treatment within 7 or 15 days at any point during the treatment process. Each of the four areas considered was helpful in identifying those who might drop out. The PDAT-13 questionnaire is brief, easy to use, and can help professionals to act quickly and keep patients in treatment.

Featured Image

Photo by Fatima Shahid on Unsplash

Photo by Fatima Shahid on Unsplash

Why is it important?

Leaving addiction treatment early is one of the greatest obstacles to successful addiction recovery, yet clinicians often lack simple tools to anticipate it. The PDAT-13 fills this gap by offering clinicians a concise, reliable, evidence-based tool that enables the early identification of at-risk patients. The PDAT-13 can improve treatment retention and enhance chances of recovery by helping professionals act early and provide personalised interventions.